Key result
Systematic whole-body 18F-FDG-PET/CT modified diagnostic classification and/or management in 40% (95% CI 32-48) of patients suspected of infective endocarditis.
Why the study?
Diagnostic and patient management modifications induced by whole-body 18F-FDG-PET/CT had not been evaluated in prosthetic valve or native valve suspected infective endocarditis.
Does systematic whole-body 18F-FDG-PET/CT modify diagnostic classification and management in patients suspected of infective endocarditis?
Cohort (n=140)
Yes
Does systematic whole-body 18F-FDG-PET/CT modify diagnostic classification and management in patients suspected of infective endocarditis?
Systematic 18F-FDG-PET/CT significantly impacts diagnostic classification and clinical management in patients with suspected native or prosthetic valve infective endocarditis.
No takes yet. Share an insight, caveat, or question.
May reclassify diagnosis or alter management in 40% of suspected IE cases; leaves open whether routine use improves outcomes.
Moing et al. (2020) conducted a cohort in Suspected infective endocarditis (n=140). Systematic whole-body 18F-Fluorodeoxyglucose PET/CT was evaluated on Modification of diagnostic classification and/or care (95% CI 32-48). Systematic whole-body 18F-FDG-PET/CT modified diagnostic classification and/or management in 40% (95% CI 32-48) of patients suspected of infective endocarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: